Omron subsidiary to invest in US medical device company
Duo eyes monitor for blood pressure, heart rate
OSAKA -- Omron Healthcare, a medical equipment subsidiary of Japanese electronics maker Omron, said Friday that it will invest $25 million in U.S. medical device venture AliveCor.
The equity stake Omron Healthcare will gain was not disclosed, but it is unlikely to exceed 30%.
AliveCor markets wearable heart rate monitors and a phone app to record results. Omron aims to use its investment to develop new products by combining AliveCor's heart rate monitors with its own blood pressure devices. The duo will jointly develop a blood pressure-heart rate monitor as well as services to prevent heart disease.
In addition to marketing heart monitors, AliveCor provides remote medical services by sending data taken from its devices directly to the patient's doctor.
Omron will use its network to expand sales of AliveCor products in Europe and elewhere.